For In Vitro Diagnostic Use
The μTASWako AFP-L3 Immunological Test System is an in vitro device that consists of reagents used with the μTASWako i30 Immunoanalyzer to quantitatively measure, by immunochemical techniques, AFP-L3% in human serum. The device is intended for in vitro diagnostic use as an aid in the risk assessment of patients with chronic liver disease for development of hepatocellular carcinoma (HCC) in conjunction with other laboratory findings, imaging studies and clinical assessment. Patients with elevated AFP-L3% values (>= 10%) have been shown to be associated with an increase in the risk of developing HCC within the next 21 months and should be more intensely evaluated for evidence of HCC according to the existing HCC practice guidelines in oncology.
Operation on μTASWako® i30 Immunoanalyzer
Catalog No. | Product Name | Pkg Size | Storage Condition |
999-60601 | μTASWako AFP-L3 | 100 tests | 2-10°C |
Calibrator | |||
997-60901 | μTASWako AFP-L3 Calibrator Set | 1 x 3 conc. x 2 mL | 2-10°C |
Control | |||
993-61101 | μTASWako AFP-L3 Control L | 4 x 1 conc. x 2 mL | 2-10°C |
997-61101 | μTASWako AFP-L3 Control H | 4 x 1 conc. x 2 mL | 2-10°C |
Related Products | |||
997-61501 | μTASWako AFP-L3 Sample Dilution Buffer | 3 x 10 mL | 2-10°C |
Consumables | |||
991-60801 | μTASWako Wash Solution | 4 x 60 mL | Room Temperature |
993-61601 | μTASWako Chip Cassette | 100 chips | Room Temperature |
452-00501 | Sample Cup S | 100 chips | Room Temperature |